Literature DB >> 12473649

Tracking the putative biosynthetic precursors of oxygenated mycolates of Mycobacterium tuberculosis. Structural analysis of fatty acids of a mutant strain deviod of methoxy- and ketomycolates.

Premkumar Dinadayala1, Francoise Laval, Catherine Raynaud, Anne Lemassu, Marie-Antoinette Laneelle, Gilbert Laneelle, Mamadou Daffe.   

Abstract

Disruption of the mma4 gene (renamed hma) of Mycobacterium tuberculosis has yielded a mutant strain defective in the synthesis of both keto- and methoxymycolates, with an altered cell-wall permeability to small molecules and a decreased virulence in the mouse model of infection (Dubnau, E., Chan, J., Raynaud, C., Mohan, V. P., Lanéelle, M. A., Yu, K., Quémard, A., Smith, I., and Daffé, M. (2000) Mol. Microbiol. 36, 630-637). Assuming that the mutant would accumulate the putative precursors of the oxygenated mycolates of M. tuberculosis, a detailed structural analysis of mycolates from the hma-inactivated strain was performed using a combination of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, proton NMR spectroscopy, and chemical degradation techniques. These consisted most exclusively of alpha-mycolates, composed of equal amounts of C(76)-C(82) dicyclopropanated (alpha(1)) and of C(77)-C(79) monoethylenic monocyclopropanated (alpha(2)) mycolates, the double bond being located at the "distal" position. In addition, small amounts of cis-epoxymycolates, structurally related to alpha(2)-mycolates, was produced by the mutant strain. Complementation of the hma-inactivated mutant with the wild-type gene resulted in the disappearance of the newly identified mycolates and the production of keto- and methoxymycolates of M. tuberculosis. Introduction of the hma gene in Mycobacterium smegmatis led to the lowering of diethylenic alpha mycolates of the recipient strain and the production of keto- and hydroxymycolates. These data indicate that long-chain ethylenic compounds may be the precursors of the oxygenated mycolates of M. tuberculosis. Because the lack of production of several methyltransferases involved in the biosynthesis of mycolates is known to decrease the virulence of the tubercle bacillus, the identification of the substrates of these enzymes should help in the design of inhibitors of the growth of M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473649     DOI: 10.1074/jbc.M210501200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

1.  Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.

Authors:  Daniel Barkan; Dorsaf Hedhli; Han-Guang Yan; Kris Huygen; Michael S Glickman
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

Review 2.  Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.

Authors:  Kuni Takayama; Cindy Wang; Gurdyal S Besra
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Requirement of the mymA operon for appropriate cell wall ultrastructure and persistence of Mycobacterium tuberculosis in the spleens of guinea pigs.

Authors:  Amit Singh; Radhika Gupta; R A Vishwakarma; P R Narayanan; C N Paramasivan; V D Ramanathan; Anil K Tyagi
Journal:  J Bacteriol       Date:  2005-06       Impact factor: 3.490

4.  Functional reconstitution of the Mycobacterium tuberculosis long-chain acyl-CoA carboxylase from multiple acyl-CoA subunits.

Authors:  Bernardo Bazet Lyonnet; Lautaro Diacovich; Gabriela Gago; Lucie Spina; Fabienne Bardou; Anne Lemassu; Annaïk Quémard; Hugo Gramajo
Journal:  FEBS J       Date:  2017-03-19       Impact factor: 5.542

5.  S-adenosyl-N-decyl-aminoethyl, a potent bisubstrate inhibitor of mycobacterium tuberculosis mycolic acid methyltransferases.

Authors:  Julien Vaubourgeix; Fabienne Bardou; Fanny Boissier; Sylviane Julien; Patricia Constant; Olivier Ploux; Mamadou Daffé; Annaïk Quémard; Lionel Mourey
Journal:  J Biol Chem       Date:  2009-05-13       Impact factor: 5.157

6.  Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.

Authors:  Jan Madacki; Françoise Laval; Anna Grzegorzewicz; Anne Lemassu; Monika Záhorszká; Michael Arand; Michael McNeil; Mamadou Daffé; Mary Jackson; Marie-Antoinette Lanéelle; Jana Korduláková
Journal:  J Biol Chem       Date:  2018-02-22       Impact factor: 5.157

Review 7.  New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.

Authors:  E Jeffrey North; Mary Jackson; Richard E Lee
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

8.  Keto-mycolic acid-dependent pellicle formation confers tolerance to drug-sensitive Mycobacterium tuberculosis.

Authors:  Dhinakaran Sambandan; Dee N Dao; Brian C Weinrick; Catherine Vilchèze; Sudagar S Gurcha; Anil Ojha; Laurent Kremer; Gurdyal S Besra; Graham F Hatfull; William R Jacobs
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

9.  The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes.

Authors:  Sylvain Cantaloube; Romain Veyron-Churlet; Nabila Haddache; Mamadou Daffé; Didier Zerbib
Journal:  PLoS One       Date:  2011-12-22       Impact factor: 3.240

10.  Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice.

Authors:  Apoorva Bhatt; Nagatoshi Fujiwara; Kiranmai Bhatt; Sudagar S Gurcha; Laurent Kremer; Bing Chen; John Chan; Steven A Porcelli; Kazuo Kobayashi; Gurdyal S Besra; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.